P3 Health Valuation
| PIII Stock | USD 2.05 0.13 6.77% |
Based on Macroaxis valuation methodology, the entity appears to be overvalued. P3 Health Partners owns a latest Real Value of $1.97 per share. The recent price of the entity is $2.05. Our model determines the value of P3 Health Partners from reviewing the entity fundamentals such as shares owned by insiders of 62.08 %, and Return On Asset of -0.21 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting P3 Health's valuation include:
Price Book 0.6248 | Enterprise Value | Enterprise Value Ebitda (1.86) | Price Sales 0.2882 | Enterprise Value Revenue 0.1623 |
Overvalued
Today
Please note that P3 Health's price fluctuation is dangerous at this time. Calculation of the real value of P3 Health Partners is based on 3 months time horizon. Increasing P3 Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since P3 Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PIII Stock. However, P3 Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.05 | Real 1.97 | Target 10.25 | Hype 2.05 | Naive 1.8 |
The intrinsic value of P3 Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence P3 Health's stock price.
Estimating the potential upside or downside of P3 Health Partners helps investors to forecast how PIII stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of P3 Health more accurately as focusing exclusively on P3 Health's fundamentals will not take into account other important factors: When choosing an evaluation method for P3 Health Partners, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
P3 Health Cash |
|
PIII Revenue by Product
P3 Health Total Value Analysis
P3 Health Partners is at this time forecasted to have valuation of 233.99 M with market capitalization of 416.45 M, debt of 166.16 M, and cash on hands of 63.15 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the P3 Health fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
233.99 M | 416.45 M | 166.16 M | 63.15 M |
P3 Health Investor Information
About 62.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.62. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. P3 Health Partners recorded a loss per share of 57.16. The entity had not issued any dividends in recent years. The firm had 1:50 split on the 14th of April 2025. P3 Health Partners is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.P3 Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. P3 Health has an asset utilization ratio of 191.53 percent. This signifies that the Company is making $1.92 for each dollar of assets. An increasing asset utilization means that P3 Health Partners is more efficient with each dollar of assets it utilizes for everyday operations.P3 Health Profitability Analysis
Considering the key profitability indicators obtained from P3 Health's historical financial statements, P3 Health Partners may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess P3 Health's ability to earn profits and add value for shareholders.Net Loss | First Reported 2020-03-31 | Previous Quarter -20.4 M | Current Value -31.6 M | Quarterly Volatility 35 M |
For P3 Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of P3 Health Partners to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well P3 Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between P3 Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of P3 Health over time as well as its relative position and ranking within its peers.
P3 Health Earnings per Share Projection vs Actual
The next projected EPS of P3 Health is estimated to be -7.82 with future projections ranging from a low of -7.8225 to a high of -7.8175. P3 Health's most recent 12-month trailing earnings per share (EPS TTM) is at -57.16. Please be aware that the consensus of earnings estimates for P3 Health Partners is based on EPS before non-recurring items and includes expenses related to employee stock options.P3 Health Earnings Estimation Breakdown
The calculation of P3 Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of P3 Health is estimated to be -7.82 with the future projection ranging from a low of -7.8225 to a high of -7.8175. Please be aware that this consensus of annual earnings estimates for P3 Health Partners is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-7.82 Lowest | Expected EPS | -7.82 Highest |
P3 Health Earnings Projection Consensus
Suppose the current estimates of P3 Health's value are higher than the current market price of the P3 Health stock. In this case, investors may conclude that P3 Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and P3 Health's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 2 | 44.36% | -9.67 | -7.82 | -57.16 |
P3 Health Ownership Allocation
The market capitalization of P3 Health Partners is $416.45 Million. P3 Health Partners owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 62.08 % of P3 Health Partners outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the entity is larger than the current market value, you may still be able to generate positive returns on investment in this company.P3 Health Profitability Analysis
The company reported the previous year's revenue of 1.5 B. Net Loss for the year was (310.38 M) with loss before overhead, payroll, taxes, and interest of (58.45 M).About P3 Health Valuation
An absolute valuation paradigm, as applied to PIII Stock, attempts to find the value of P3 Health Partners based on its fundamental and basic technical indicators. By analyzing P3 Health's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of P3 Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of P3 Health. We calculate exposure to P3 Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of P3 Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.7 B | 1.8 B | |
| Pretax Profit Margin | (0.23) | (0.25) | |
| Operating Profit Margin | (0.25) | (0.26) | |
| Net Loss | (0.08) | (0.09) | |
| Gross Profit Margin | (0.04) | (0.05) |
P3 Health Current Valuation Indicators
Valuation refers to the process of determining the present value of P3 Health Partners and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value PIII we look at many different elements of the entity such as PIII's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as P3 Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use P3 Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes P3 Health's worth.Complementary Tools for PIII Stock analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |